Moreover, Oncomine LGR5 gene expression data from patients obtained in RNA‐Seq experiments showed that the expression levels of LGR5 in ovarian cancer patients were augmented in stages III and IV, relative to that in normal tissues (Fig. 1D). This evidence concerns the gene LGR5 and ovarian cancer.